SG/PUT/DERMAPHARM HOLDING/32/0.1/20.12.24 Share Price

Warrant

DE000SU9LJN5

Real-time Bid/Ask 09:11:09 27/06/2024 BST
0.19 EUR / 0.2 EUR -2.50% Intraday chart for SG/PUT/DERMAPHARM HOLDING/32/0.1/20.12.24
1 month+5.26%
3 months-33.33%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
27/06/24 0.19 -5.00%
26/06/24 0.2 +11.11%
25/06/24 0.18 -5.26%
24/06/24 0.19 0.00%
21/06/24 0.19 0.00%

Delayed Quote Börse Stuttgart

Last update June 27, 2024 at 07:11 am

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying DERMAPHARM HOLDING SE
IssuerLogo Issuer Société Générale Société Générale
WKN SU9LJN
ISINDE000SU9LJN5
Date issued 20/02/2024
Strike 32
Maturity 20/12/2024 (177 Days)
Parity 10 : 1
Emission price 0.23
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.4
Lowest since issue 0.15
Delta-0.28x
Omega 5.210
Premium16.76x
Gearing18.51x
Moneyness 0.8864
Difference Strike -4.2
Difference Strike %-13.13%
Spread 0.01
Spread %5.00%
Theoretical value 0.1950
Implied Volatility 38.21 %
Total Loss Probability 61.56 %
Intrinsic value 0.000000
Present value 0.1950
Break even 30.05 €
Theta-0.01x
Vega0.01x
Rho-0.01x

Company Profile

Dermapharm Holding SE is a Germany-based company engaged in manufacturing of patent-free branded pharmaceuticals. The Company operates through two segments: Branded pharmaceuticals and other healthcare products, which includes in-house development, in-house production, and distribution of branded pharmaceuticals and other healthcare products, and Parallel import business, which operates under the axicorp brand. It holds around 950 marketing authorizations for more than 250 active pharmaceutical ingredients, which are marketed as pharmaceuticals, dietary supplements or supplemental balanced diets. The Company offers its products through a number of brands, including Dekristol, Ampho Moronal, Keltican, Tromcardin, among others. It is active primarily in Germany, Switzerland and Austria. Additionally, it operates production facility in Germany. Trommsdorff & GmbH Co KG is a subsidiary of the Company.
Sector
-
More about the company

Ratings for Dermapharm Holding SE

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Dermapharm Holding SE

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
36 EUR
Average target price
50.12 EUR
Spread / Average Target
+39.24%
Consensus